ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

India COVID crisis raises pressure on US to waive vaccine patents

Emerging countries push for a WTO-rule exemption amid surging infections

A coronavirus patient receives treatment at a hospital in New Delhi: India's flood of new infections has caused a severe shortage of oxygen for medical use.   © Reuters
RINTARO HOSOKAWA and TAISEI HOYAMA, Nikkei staff writers | North America

VIENNA/WASHINGTON -- Facing pressure amid renewed surges in coronavirus cases in India and other emerging countries, the U.S. has begun considering loosening vaccine patent protections to increase global access to the shots.

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close